Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Owens & Minor Reports Second Quarter 2023 Financial Results
Owens & Minor Reports Second Quarter 2023 Financial Results


Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023.



Second Quarter Key Highlights:




  • Consolidated revenue of $2.56 billion


  • Net loss

H1 2023 result outperforms prior year at constant exchange rates
H1 2023 result outperforms prior year at constant exchange rates
H1 2023 result outperforms prior year at constant exchange rates
NanoString Technologies Releases Operating Results for Second Quarter of 2023
NanoString Technologies Releases Operating Results for Second Quarter of 2023


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June

Agilent Announces Thought Leader Award to Peter Neubauer: https://unsplash.com/photos/WUehAgqO5hE
Agilent Announces Thought Leader Award to Peter Neubauer


Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award. As Chair of Bioprocess Engineering at the Technical

STAAR Surgical Reports Second Quarter 2023 Results
STAAR Surgical Reports Second Quarter 2023 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals


Agilent Technologies Inc. (NYSE: A) today released its 2022 ESG report on the company’s work supporting customers with their sustainability initiatives while advancing its own internal

EQS-News: Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants
EQS-News: Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants
EQS-News: Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants
EQS-Adhoc: MeVis Medical Solutions AG:  Adjusting forecast for the current fiscal year
EQS-Adhoc: MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
EQS-Adhoc: MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
EQS-News: MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group
EQS-News: MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group
EQS-News: MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group
Dexcom Reports Second Quarter 2023 Financial Results
Dexcom Reports Second Quarter 2023 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023.



Second Quarter 2023 Financial Highlights:




  • Revenue grew 25% versus the same

Acadia Healthcare Reports Second Quarter 2023 Results and Raises 2023 Guidance
Acadia Healthcare Reports Second Quarter 2023 Results and Raises 2023 Guidance


Acadia Healthcare Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2023.



Second Quarter and Recent Highlights




  • Revenue totaled

Chemed Reports Second-Quarter 2023 Results
Chemed Reports Second-Quarter 2023 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

LivaNova Reports Second-Quarter 2023 Results
LivaNova Reports Second-Quarter 2023 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023 and raised full-year 2023 guidance.



Financial Summary and

QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion

Methodist Jennie Edmundson Hospital Partners With Acadia Healthcare to Build New Behavioral Health Hospital in Council Bluffs
Methodist Jennie Edmundson Hospital Partners With Acadia Healthcare to Build New Behavioral Health Hospital in Council Bluffs


According to American Hospital Directory data, there is a shortfall of more than 300 inpatient behavioral health beds in Iowa and Nebraska.



To address this need, Methodist Jennie Edmundson

Acadia Healthcare Forms Joint Venture Partnership With Nebraska Methodist Health System
Acadia Healthcare Forms Joint Venture Partnership With Nebraska Methodist Health System


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced today that it has formed a joint venture with Nebraska Methodist Health System to build a state-of-the-art, 96-bed behavioral health

QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
Owens & Minor Announces Second Quarter 2023 Earnings Release Date and Conference Call
Owens & Minor Announces Second Quarter 2023 Earnings Release Date and Conference Call


Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2023 on Friday, August 4, 2023, before trading begins on the New York Stock Exchange.



The Company

Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
Premier, Inc. to Report Fiscal 2023 Fourth-Quarter and Full-Year Results and Host Conference Call on August 22, 2023
Premier, Inc. to Report Fiscal 2023 Fourth-Quarter and Full-Year Results and Host Conference Call on August 22, 2023


Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2023 fourth quarter and full year on Tuesday, August 22, 2023, at approximately 6:30 a.m. ET. The

Agilent to Announce Third-Quarter Fiscal Year 2023 Financial Results Aug. 15Photo, wide shot, wide-angle lens, soft focus,  Reinsurance company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-bSRc7PrRT00tZTDNf9SggMTD.png?st=2023-05-06T18%3A48%3A49Z&se=2023-05-06T20%3A48%3A49Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A38%3A49Z&ske=2023-05-07T00%3A38%3A49Z&sks=b&skv=2021-08-06&sig=3seGuy7NQJX9RXUOWr6XArANokWXlKqwnEJxEHfdbSY%3D
Agilent to Announce Third-Quarter Fiscal Year 2023 Financial Results Aug. 15


Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2023 after the stock market closes on Tuesday, Aug. 15. In addition, the company will host a

STAAR Surgical to Report Second Quarter Results on August 2, 2023
STAAR Surgical to Report Second Quarter Results on August 2, 2023


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the second